This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Bionature E.a. Limited. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Eumorphia Remboutsika: Innovator in Neurosteroid Compounds
Introduction
Eumorphia Remboutsika is a notable inventor based in Vari, Greece. He has made significant contributions to the field of neurosteroid compounds, focusing on their potential applications in treating neurodegenerative diseases. His innovative work has garnered attention for its implications in neuroscience and medicine.
Latest Patents
Remboutsika holds a patent for neurosteroid compounds, which are novel derivatives with anti-apoptotic, neuroprotective, and neurogenic properties. These compounds act on the nervous system and are designed to treat or prevent conditions related to neuronal apoptosis or injury. His patent addresses various neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and multiple sclerosis, among others. The active compounds are represented by a specific formula, which is detailed in the patent description.
Career Highlights
Eumorphia Remboutsika has established himself as a key figure in the field of neurobiology. His work at Bionature E.A. Limited has allowed him to explore the therapeutic potential of neurosteroids extensively. With a focus on innovative solutions for complex neurological conditions, he continues to push the boundaries of current medical understanding.
Collaborations
Remboutsika has collaborated with esteemed colleagues, including Achilleas Gravanis and Theodora Calogeropoulou. These partnerships have enriched his research and contributed to the advancement of neurosteroid applications in medicine.
Conclusion
Eumorphia Remboutsika's contributions to neurosteroid compounds represent a significant advancement in the treatment of neurodegenerative diseases. His innovative approach and dedication to research continue to inspire progress in the field of neuroscience.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile